LUNG CARCINOMA

This phase 2 trial tests a vaccine called SurVaxM in 80 current or former smokers at high risk for lung cancer. The vaccine trains the immune system to attack cells that make a protein called survivin, which is common in early cancer cells. If successful, the vaccine could help p…

This study tests if doing breathing exercises with a handheld device and cycling on a stationary bike at home can improve lung health in current and former smokers aged 50 and older. The goal is to see if these programs are practical and can help lower the risk of lung cancer. Tw…

This study will follow 100 people with a type of lung cancer that shows up well on a CEA blood test. Researchers want to see if changes in CEA and another test called ctDNA can predict if the cancer returns after surgery. The goal is to catch recurrence early and help doctors per…

This study tests whether a special decision-making program, based on restorative justice, can help more Black individuals get screened for lung cancer. Lung cancer is the top cancer killer among Black men and women, and screening can lower deaths by 20%, but use is low. The progr…

This study tests a new method called CORRECT to help radiologists and radiation oncologists better communicate when planning radiation therapy for lung and head & neck cancers. About 194 patients will take part. The goal is to see if this workflow can be used in everyday practice…

This study looks at whether personalized patient navigation can help more American Indian and Alaska Native people in Washington state get screened for lung cancer. Lung cancer is a leading cause of death in these communities, and screening rates are low. The trial will enroll 23…